Jintao Gu1, Nan Mu2, Bo Jia3, Qingdong Guo3, Luxiang Pan1, Maorong Zhu1, Wangqian Zhang1, Kuo Zhang1, Weina Li1, Meng Li1, Lichun Wei4, Xiaochang Xue5, Yingqi Zhang1, Wei Zhang1. 1. State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, China. 2. Department of Physiology and Pathophysiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, China. 3. Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China. 4. Department of Radiotherapy, Xijing Hospital, Fourth Military Medical University, Xi'an, China. 5. College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Abstract
BACKGROUND: Compelling evidence suggests that glioblastoma (GBM) recurrence results from the expansion of a subset of tumor cells with robust intrinsic or therapy-induced radioresistance. However, the mechanisms underlying GBM radioresistance and recurrence remain elusive. To overcome obstacles in radioresistance research, we present a novel preclinical model ideally suited for radiobiological studies. METHODS: With this model, we performed a screen and identified a radiation-tolerant persister (RTP) subpopulation. RNA sequencing was performed on RTP and parental cells to obtain mRNA and miRNA expression profiles. The regulatory mechanisms among NF-κB, YY1, miR-103a, XRCC3, and FGF2 were investigated by transcription factor activation profiling array analysis, chromatin immunoprecipitation, western blot analysis, luciferase reporter assays, and the MirTrap system. Transferrin-functionalized nanoparticles (Tf-NPs) were employed to improve blood-brain barrier permeability and RTP targeting. RESULTS: RTP cells drive radioresistance by preferentially activating DNA damage repair and promoting stemness. Mechanistic investigations showed that continual radiation activates the NF-κB signaling cascade and promotes nuclear translocation of p65, leading to enhanced expression of YY1, the transcription factor that directly suppresses miR-103a transcription. Restoring miR-103a expression under these conditions suppressed the FGF2-XRCC3 axis and decreased the radioresistance capability. Moreover, Tf-NPs improved radiosensitivity and provided a significant survival benefit. CONCLUSIONS: We suggest that the NF-κB-YY1-miR-103a regulatory axis is indispensable for the function of RTP cells in driving radioresistance and recurrence. Thus, our results identified a novel strategy for improving survival in patients with recurrent/refractory GBM. Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2021.
BACKGROUND: Compelling evidence suggests that glioblastoma (GBM) recurrence results from the expansion of a subset of tumor cells with robust intrinsic or therapy-induced radioresistance. However, the mechanisms underlying GBM radioresistance and recurrence remain elusive. To overcome obstacles in radioresistance research, we present a novel preclinical model ideally suited for radiobiological studies. METHODS: With this model, we performed a screen and identified a radiation-tolerant persister (RTP) subpopulation. RNA sequencing was performed on RTP and parental cells to obtain mRNA and miRNA expression profiles. The regulatory mechanisms among NF-κB, YY1, miR-103a, XRCC3, and FGF2 were investigated by transcription factor activation profiling array analysis, chromatin immunoprecipitation, western blot analysis, luciferase reporter assays, and the MirTrap system. Transferrin-functionalized nanoparticles (Tf-NPs) were employed to improve blood-brain barrier permeability and RTP targeting. RESULTS: RTP cells drive radioresistance by preferentially activating DNA damage repair and promoting stemness. Mechanistic investigations showed that continual radiation activates the NF-κB signaling cascade and promotes nuclear translocation of p65, leading to enhanced expression of YY1, the transcription factor that directly suppresses miR-103a transcription. Restoring miR-103a expression under these conditions suppressed the FGF2-XRCC3 axis and decreased the radioresistance capability. Moreover, Tf-NPs improved radiosensitivity and provided a significant survival benefit. CONCLUSIONS: We suggest that the NF-κB-YY1-miR-103a regulatory axis is indispensable for the function of RTP cells in driving radioresistance and recurrence. Thus, our results identified a novel strategy for improving survival in patients with recurrent/refractory GBM. Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2021.
Entities:
Keywords:
DNA damage repair; glioblastoma; glioma stem cell; radioresistance
Authors: Sergey Karakashev; Takeshi Fukumoto; Bo Zhao; Jianhuang Lin; Shuai Wu; Nail Fatkhutdinov; Pyoung-Hwa Park; Galina Semenova; Stephanie Jean; Mark G Cadungog; Mark E Borowsky; Andrew V Kossenkov; Qin Liu; Rugang Zhang Journal: Cancer Cell Date: 2020-01-30 Impact factor: 31.743
Authors: Erik P Sulman; Nofisat Ismaila; Terri S Armstrong; Christina Tsien; Tracy T Batchelor; Tim Cloughesy; Evanthia Galanis; Mark Gilbert; Vinai Gondi; Mary Lovely; Minesh Mehta; Matthew P Mumber; Andrew Sloan; Susan M Chang Journal: J Clin Oncol Date: 2016-11-28 Impact factor: 44.544
Authors: Jing Hu; Tao Sun; Hui Wang; Zhengxin Chen; Shuai Wang; Lifeng Yuan; Tingyu Liu; Hai-Ri Li; Pingping Wang; Yukuan Feng; Qinhong Wang; Roger E McLendon; Allan H Friedman; Stephen T Keir; Darell D Bigner; Jeff Rathmell; Xiang-Dong Fu; Qi-Jing Li; Huibo Wang; Xiao-Fan Wang Journal: Cancer Cell Date: 2016-01-11 Impact factor: 31.743